With the federal agency’s premarket notification 510(k), Medtronic’s system is cleared for patients older than 2 years old who have heart rhythm abnormalities and need long-term monitoring, according to a Medtronic news release.
The device has been commercially available since 2020 and is currently in the FDA’s approval process for use in pediatric populations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
